What is the difference between hypotonic hyponatremia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH)?

Hypotonic Hyponatremia vs SIADH: Understanding the Relationship

SIADH is not different from hypotonic hyponatremia—rather, SIADH is a specific cause of euvolemic hypotonic hyponatremia. Hypotonic hyponatremia is the broader laboratory finding (low serum sodium with low plasma osmolality), while SIADH represents one particular mechanism causing this finding 1.

The Conceptual Framework

Hypotonic Hyponatremia: The Umbrella Category

Hypotonic hyponatremia refers to any condition where:

• Serum sodium < 135 mEq/L (some use < 134 mEq/L)
• Plasma osmolality < 275 mOsm/kg

This is a laboratory finding that can result from multiple different pathophysiologic mechanisms 2.

Volume Status Classification

Hypotonic hyponatremia is subdivided based on volume status into three categories 3, 4:

Hypovolemic hyponatremia:

• Decreased total body water AND decreased total body sodium
• Causes: excessive diuretics, renal salt wasting, GI losses, third-spacing
• Clinical signs: no ascites or edema, signs of dehydration
• Treatment: volume expansion with saline

Euvolemic hyponatremia:

• Normal or slightly increased total body water with normal total body sodium
• SIADH is the most common cause in this category 1
• Other causes: hypothyroidism, adrenal insufficiency, medications
• Clinical signs: no edema, no ascites, clinically euvolemic

Hypervolemic hyponatremia:

• Increased total body water AND increased total body sodium
• Causes: cirrhosis, heart failure, nephrotic syndrome
• Clinical signs: ascites, edema, volume overload 3

SIADH: A Specific Diagnosis

Diagnostic Criteria for SIADH

SIADH is diagnosed when ALL of the following are present 1:

• Hyponatremia (serum sodium < 134 mEq/L)
• Hypoosmolality (plasma osmolality < 275 mOsm/kg)
• Inappropriately high urine osmolality (> 300-500 mOsm/kg)
• Inappropriately high urinary sodium (> 20-40 mEq/L)
• Clinical euvolemia (no edema, ascites, or dehydration)
• Absence of:
  • Hypothyroidism
  • Adrenal insufficiency
  • Diuretic use
  • Heart failure
  • Cirrhosis
  • Renal insufficiency

The Pathophysiology

In SIADH, excess ADH activates vasopressin V2 receptors in renal collecting ducts, causing increased aquaporin expression and impaired free water clearance 1. This results in water retention without proportional sodium retention, leading to dilutional hyponatremia. Despite increased total body water, patients appear clinically euvolemic because physiologic natriuresis maintains fluid balance at the expense of plasma sodium 5.

Key Distinguishing Features

What Makes SIADH Different from Other Hypotonic Hyponatremias

The critical distinguishing feature is the inappropriately concentrated urine in the setting of plasma hypoosmolality 1.

In normal physiology:

• Low plasma osmolality → suppressed ADH → dilute urine (< 100 mOsm/kg)

In SIADH:

• Low plasma osmolality → persistent ADH activity → concentrated urine (> 300 mOsm/kg)

This is "inappropriate" because the kidneys should be excreting maximally dilute urine to correct the hyponatremia, but they cannot due to ongoing ADH activity.

Additional Diagnostic Clues

Hypouricemia (serum uric acid < 4 mg/dL) is a distinguishing feature of SIADH 1, 6, 7. The fractional excretion of urate can improve diagnostic accuracy to 95% 1.

Common Causes of SIADH

The most frequent etiologies include 1, 8:

Malignancy:

• Small cell lung cancer (10-45% produce ADH, 1-5% symptomatic)
• Other lung cancers (squamous cell, adenocarcinoma)

Pulmonary disorders:

• Pneumonia
• Tuberculosis

CNS disorders:

• Meningitis
• Encephalitis
• Subarachnoid hemorrhage
• Head trauma

Medications (most common overall):

• SSRIs, carbamazepine, cyclophosphamide, vincristine, NSAIDs, opiates

Postoperative state:

• Pain, nausea, stress all stimulate non-osmotic ADH release 5

Critical Clinical Pitfall

Hospital-acquired hyponatremia is frequently iatrogenic 8, 9, 6. Administering hypotonic IV fluids (D5W, 0.45% saline) to patients with SIADH or elevated ADH states will worsen hyponatremia, as these patients cannot excrete free water. Even isotonic saline (0.9% NaCl) can paradoxically worsen hyponatremia in SIADH because the kidneys excrete the sodium while retaining the water 8, 6.

Symptom Severity and Mortality Risk

Symptoms correlate with both the degree and acuity of hyponatremia 1:

• 125-130 mEq/L: weakness, confusion, headache, nausea
• < 120 mEq/L: seizures, coma, death possible
• Acute onset (< 48 hours): higher risk of hyponatremic encephalopathy, particularly in children due to larger brain/skull ratio 5

Hyponatremia in SCLC patients is associated with shortened survival 1.

Treatment Approach Differences

For SIADH Specifically

First-line: Fluid restriction < 1 L/day 1

• Often ineffective as sole therapy in practice
• Prevents further decline but rarely improves sodium

Second-line options:

• Vaptans (tolvaptan, conivaptan): V2 receptor antagonists that selectively block ADH effect, improving sodium in 45-82% of cases 3, 4
• Oral urea: very effective and safe 10
• Demeclocycline, lithium (less commonly used due to side effects)

For severe symptomatic SIADH (< 120 mEq/L with neurologic symptoms):

• 3% hypertonic saline IV 1
• Correct 6 mmol/L over first 6 hours or until symptoms resolve 11
• Total correction must not exceed 8-10 mmol/L per 24 hours to avoid osmotic demyelination syndrome 4

For Other Hypotonic Hyponatremias

Hypovolemic: Volume expansion with normal saline, stop diuretics 4

Hypervolemic (cirrhosis, heart failure): Fluid restriction, treat underlying condition, consider vaptans for refractory cases 3, 2

The treatment fundamentally differs because the underlying pathophysiology differs—giving saline to hypovolemic patients corrects the problem, while giving saline to SIADH patients can worsen it.